Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

Cancer Immunology, Immunotherapy · Published 2021-10-01 · Available online 12 Jun 2021 · Journal article · DOI 10.1007/s00262-021-02961-0 · PMID: 34120214 · PMC · Cited by 16 (Crossref)

Authors (11)

Brigitte Dréno, Amir Khammari, Agnès Fortun, Virginie Vignard, Soraya Saiagh, Tiffany Beauvais, Nicolas Jouand, Sylvain Bercegay, Sylvain Simon, François Lang, Nathalie Labarrière

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

70

Issue

10

Pages

3015-3030

Year

2021

Citation

Dréno, B., Khammari, A., Fortun, A., et al. (2021). Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-021-02961-0

Related articles

• Immuno-oncology approaches to overcome T cell exhaustion in melanoma · Seminars in Oncology · 2025 · Cites or is cited by this article
• The identity crisis of cryptic lncRNAs: when non-coding RNAs translate into small peptides · EMBO Journal · 2026 · Cites or is cited by this article
• Identification of the molecular subtype and prognostic characteristics of lung adenocarcinoma based on CD8 + T cell-related gene signature · Cancer Biomarkers · 2024 · Cites or is cited by this article
• The Landscape of Clinical Trials for TCR-T Cell Therapy · American Journal of Clinical Oncology: Cancer Clinical Trials · 2025 · Cites or is cited by this article
• HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · Cancer Immunology, Immunotherapy · 2026 · Same journal

Metrics

Citations (Crossref)

16